That biotech uni­corn you (pick love or hate) just spot­light­ed some in­trigu­ing mouse (yes) da­ta on a triple mR­NA can­cer ther­a­py

The can­cer team work­ing un­der Mod­er­na’s Tal Zaks have been tin­ker­ing with var­i­ous com­bi­na­tions of mR­NA in mice to see how best they can use this tech­nol­o­gy to or­ches­trate an im­mune sys­tem at­tack. And to­day they’re high­light­ing a pre­clin­i­cal ro­dent study that in­di­cates they could be on a promis­ing path that’s tak­en them in­to hu­man tri­als.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER